Literature DB >> 14752284

Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with markedly elevated interleukin 6 levels.

Isaiah R Turnbull1, Pardis Javadi, Timothy G Buchman, Richard S Hotchkiss, Irene E Karl, Craig M Coopersmith.   

Abstract

Genetically identical mice have a heterogeneous response to antibiotic therapy in sepsis, with only a subset deriving therapeutic benefit. We sought to determine whether the severity of a septic insult correlates with the survival benefit conferred by antibiotics. We also sought to determine whether antibiotics given 12 h after injury alter survival in animals predicted to die based upon high interleukin (IL)-6 levels drawn 6 h earlier. Adult male ND4 mice (n = 363) were subjected to double-puncture cecal ligation and puncture (CLP) with a 19-, 21-, or 23-gauge needle. Animals were randomized to receive imipenem or 0.9% NaCl every 12 h after CLP for 5 days. Ten-day survival was 16%, 26%, and 52%, respectively, for untreated animals. Antibiotics decreased the absolute risk of death 17% to 23% regardless of injury severity. In a separate cohort, mice (n = 37) were subjected to single or double-puncture CLP with a 21-gauge needle. IL-6 levels were assayed 6 h postoperatively and mice were followed for survival. Levels greater than 14,000 pg/mL were identified as predicting a 100% mortality (7/7 animals dead). A third set of mice (n = 94) then underwent double-puncture CLP with either 21-, 23-, or 25-gauge needle and had IL-6 levels measured in a similar fashion. Animals were randomized to receive imipenem or 0.9% NaCl beginning 12 h postoperatively (6 h after IL-6 levels were drawn) and continued for 5 days or until death. Although antibiotics decreased mortality overall, all animals with IL-6 levels greater than 14,000 pg/mL (n = 13) died, regardless of whether they received antibiotics or the gauge of needle used. These results indicate that antibiotics improve outcome in murine sepsis, regardless of injury severity. Furthermore, there is a threshold IL-6 level that can be identified 6 h after sepsis above which animals are destined to die, and antibiotic treatment does not alter their outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14752284     DOI: 10.1097/01.shk.0000108399.56565.e7

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  42 in total

1.  Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice.

Authors:  Yanli Ding; Chun-Shiang Chung; Sarah Newton; Yaping Chen; Stacey Carlton; Jorge E Albina; Alfred Ayala
Journal:  Shock       Date:  2004-08       Impact factor: 3.454

Review 2.  Differential Paradigms in Animal Models of Sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

3.  Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis.

Authors:  Marcin F Osuchowski; Judith Connett; Kathleen Welch; Jill Granger; Daniel G Remick
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

4.  Reply to "Bacterial Proliferation May Be the Key Component of Sepsis Mortality".

Authors:  Antonio De Maio
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

5.  Trial of short-course antimicrobial therapy for intraabdominal infection.

Authors:  Robert G Sawyer; Jeffrey A Claridge; Avery B Nathens; Ori D Rotstein; Therese M Duane; Heather L Evans; Charles H Cook; Patrick J O'Neill; John E Mazuski; Reza Askari; Mark A Wilson; Lena M Napolitano; Nicholas Namias; Preston R Miller; E Patchen Dellinger; Christopher M Watson; Raul Coimbra; Daniel L Dent; Stephen F Lowry; Christine S Cocanour; Michaela A West; Kaysie L Banton; William G Cheadle; Pamela A Lipsett; Christopher A Guidry; Kimberley Popovsky
Journal:  N Engl J Med       Date:  2015-05-21       Impact factor: 91.245

Review 6.  Current Murine Models of Sepsis.

Authors:  Anthony J Lewis; Christopher W Seymour; Matthew R Rosengart
Journal:  Surg Infect (Larchmt)       Date:  2016-06-15       Impact factor: 2.150

7.  Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide.

Authors:  Tamika Burns; Maria Abadi; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

8.  Chronic sepsis mortality characterized by an individualized inflammatory response.

Authors:  Marcin F Osuchowski; Kathy Welch; Huan Yang; Javed Siddiqui; Daniel G Remick
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

9.  Sepsis-induced inflammation is exacerbated in an animal model of type 2 diabetes.

Authors:  Asha Jacob; Marissa L Steinberg; Juntao Yang; Weifeng Dong; Youxin Ji; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-10

10.  Sepsis Biomarkers.

Authors:  Yachana Kataria; Daniel Remick
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.